Bildgebung von neuroendokrinen Tumoren des PankreasImaging of pancreatic neuroendocrine tumors

[1] Ambrosini V(2015)Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas J Nucl Med 56 1843-1848

[2] Campana D(2008)Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Eur J Nucl Med Mol Imaging 35 1431-1438

[3] Polverari G(2014)Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms Dig Liver Dis 46 9-17

[4] Ambrosini V(2018)Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies Lancet Diabetes Endocrinol 6 404-415

[5] Tomassetti P(2016)Gastroenteropancreatic neuroendocrine tumours (GEP-NET)—Imaging and staging Best Pract Res Clin Endocrinol Metab 30 45-57

[6] Castellucci P(2010)18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors Clin Cancer Res 16 978-985

[7] Attili F(2017)Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism Clin Nucl Med 42 15-19

[8] Capurso G(2012)Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection Eur J Radiol 81 e746-e749

[9] Vanella G(2018)Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery J Magn Reson Imaging 47 425-432

[10] Auernhammer CJ(2008)Response evaluation of gastrointestinal stromal tumors Oncologist 13 4-7

[1] Ambrosini V(2015)Prognostic Value of 68Ga-DOTANOC PET/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas J Nucl Med 56 1843-1848

[2] Campana D(2008)Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours Eur J Nucl Med Mol Imaging 35 1431-1438

[3] Polverari G(2014)Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms Dig Liver Dis 46 9-17

[4] Ambrosini V(2018)Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies Lancet Diabetes Endocrinol 6 404-415

[5] Tomassetti P(2016)Gastroenteropancreatic neuroendocrine tumours (GEP-NET)—Imaging and staging Best Pract Res Clin Endocrinol Metab 30 45-57

[6] Castellucci P(2010)18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors Clin Cancer Res 16 978-985

[7] Attili F(2017)Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism Clin Nucl Med 42 15-19

[8] Capurso G(2012)Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection Eur J Radiol 81 e746-e749

[9] Vanella G(2018)Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery J Magn Reson Imaging 47 425-432

[10] Auernhammer CJ(2008)Response evaluation of gastrointestinal stromal tumors Oncologist 13 4-7